Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Metformin

EU orphan designation number: EU/3/16/1803   
Active ingredient: Metformin
Indication: Treatment of progressive myoclonic epilepsy type 2 (Lafora disease)
Sponsor: Centro de Investigación Biomédica en Red (CIBER)
Instituto de Salud Carlos III, Pabellón 11, Planta 0, C/ Monforte de Lemos 3-5, 28029 Madrid, España

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/12/2016 Orphan designation EMA/OD/179/16 (2016)8703 of 12/12/2016